AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway
Yizhi Zhang(Jiangnan University), Jinhua Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 6
Related Papers
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
|Drug Resistance Updates|2023|236
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
|Biochemical Pharmacology|2020|160
Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells
|Free Radical Biology and Medicine|2017|136
Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs
|JNCI Journal of the National Cancer Institute|2013|131
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
|Journal of Translational Medicine|2022|112